Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 241–255 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3783 TTR Gene Amyloidosis Genetic Test This test identifies pathogenic variants in the TTR gene associated with hereditary transthyretin amyloidosis.	Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TTR gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "Avoid strenuous exercise 2 hours before collection", "Prior genetic counselling is mandatory"] Indications ["Suspected hereditary ATTR amyloidosis", "Family history of ATTR amyloidosis", "Screening of at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E85.2 Clinical summary This test identifies pathogenic variants in the TTR gene associated with hereditary transthyretin amyloidosis.
TEST-4102 TUBB2A Gene Cortical Dysplasia, Complex with Other Brain Malformations Type 5 Genetic Test This test identifies pathogenic variants in the TUBB2A gene associated with cortical dysplasia, complex with other brain malformations type 5.	Peripheral Whole Blood (2 EDTA tubes), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TUBB2A gene sequence", "Pathogenic variants in coding exons and splice sites"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected cortical dysplasia, complex with other brain malformations type 5", "Drug-resistant epilepsy", "Family history of related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: Q04.5 Clinical summary This test identifies pathogenic variants in the TUBB2A gene associated with cortical dysplasia, complex with other brain malformations type 5.
TEST-2915 TWIST1 Gene Craniosynostosis Type 1 Genetic Test This test evaluates the TWIST1 gene for pathogenic variants associated with craniosynostosis syndromes like Saethre-Chotzen syndrome.	Whole blood (EDTA), FTA card, or extracted DNA	3–4 weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TWIST1 gene"] Parameters [] Preparation [] Indications ["Suspected Saethre-Chotzen syndrome", "Isolated craniosynostosis", "Paediatric differential diagnosis", "Surgical planning", "Family genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 101261-4 ICD-10: Q75.0, Q87.0 Clinical summary This test evaluates the TWIST1 gene for pathogenic variants associated with craniosynostosis syndromes like Saethre-Chotzen syndrome.
TEST-5961 UMPS Gene Orotic Aciduria Genetic Test This test evaluates the UMPS gene for mutations associated with hereditary orotic aciduria, a rare metabolic disorder.	Peripheral Whole Blood (3-5 mL in EDTA tube) or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the UMPS gene", "Single nucleotide variants", "Indels", "Copy number variations"] Parameters [] Preparation ["None specified"] Indications ["Suspected hereditary orotic aciduria", "Family history of orotic aciduria", "Evaluation of pyrimidine metabolism disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82863-9 ICD-10: E79.0 Clinical summary This test evaluates the UMPS gene for mutations associated with hereditary orotic aciduria, a rare metabolic disorder.
TEST-4509 UVSSA Gene UV-Sensitive Syndrome Type 3 Genetic Test This test identifies pathogenic variants in the UVSSA gene associated with UV-sensitive syndrome type 3.	Blood, Extracted DNA, or One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UVSSA gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of UV-sensitive syndrome type 3", "Family history of UV-sensitive syndrome type 3"] Measurement technique Confirm with laboratory Codes LOINC: 95821-3 ICD-10: Q82.8, L56.8 Clinical summary This test identifies pathogenic variants in the UVSSA gene associated with UV-sensitive syndrome type 3.
TEST-2921 VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome Genetic Test This test evaluates the VSX1 gene for pathogenic variants associated with craniofacial anomalies and anterior segment dysgenesis syndrome.	Peripheral Whole Blood (Venipuncture)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in the VSX1 gene", "Small insertions/deletions in the VSX1 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed"] Indications ["Clinical suspicion of craniofacial anomalies and anterior segment dysgenesis syndrome", "Family history of VSX1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.0 Clinical summary This test evaluates the VSX1 gene for pathogenic variants associated with craniofacial anomalies and anterior segment dysgenesis syndrome.
TEST-5866 WDR27 Gene Sequencing for Brain Disorders (Genetic Test) This test analyzes the entire WDR27 gene to identify pathogenic variants associated with hereditary neurological disorders.	Whole Blood, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the WDR27 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["Fasting is not required", "Sample can be collected at any time"] Indications ["Confirmation of genetic diagnosis for hereditary brain disorders", "Guiding treatment planning", "Family counseling", "Carrier detection"] Measurement technique Confirm with laboratory Codes LOINC: 81322-1 ICD-10: G11.8, Q04.8 Clinical summary This test analyzes the entire WDR27 gene to identify pathogenic variants associated with hereditary neurological disorders.
TEST-4738 WNT10A Gene Odontoonychodermal Dysplasia Genetic Test This genetic test analyzes the WNT10A gene to identify mutations associated with odontoonychodermal dysplasia.	Peripheral Blood (Whole Blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WNT10A gene coding region variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Clinical features of odontoonychodermal dysplasia", "Positive family history of ectodermal dysplasia syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 82870-0 ICD-10: Q82.4, Z14.8, Z13.228 Clinical summary This genetic test analyzes the WNT10A gene to identify mutations associated with odontoonychodermal dysplasia.
TEST-4755 XBP1 Gene Genetic Testing for Major Affective Disorders Test This test identifies genetic variants in the XBP1 gene associated with an increased risk of developing major affective disorders.	Peripheral Whole Blood (3–5 mL EDTA tube) or DNA FTA Card	21–28 Days (3 to 4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["XBP1 gene variants", "Pathogenic variants in coding exons and flanking intronic regions"] Parameters [] Preparation ["Pre-test genetic counseling session required", "Provide list of current psychiatric medications"] Indications ["Suspected genetic predisposition to major affective disorders", "Risk stratification for bipolar disorder", "Risk stratification for recurrent major depressive disorder"] Measurement technique Confirm with laboratory Codes LOINC: 98538-4 ICD-10: F30–F39 Clinical summary This test identifies genetic variants in the XBP1 gene associated with an increased risk of developing major affective disorders.
TEST-2610 XK Gene Genetic Test for McLeod Syndrome & CGD This test evaluates the XK gene for pathogenic variants associated with McLeod syndrome and assesses for contiguous deletions involving the CYBB gene linked to X-linked CGD.	Whole Blood (EDTA tube), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the XK gene", "Contiguous deletions involving XK and CYBB genes"] Parameters [] Preparation ["Clinical history must be provided", "Mandatory genetic counseling session required", "No fasting required"] Indications ["Suspected McLeod syndrome", "Suspected X-linked Chronic Granulomatous Disease (CGD)", "Family history of McLeod syndrome or CGD", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 74500-4 ICD-10: G23.0, D70.4 Clinical summary This test evaluates the XK gene for pathogenic variants associated with McLeod syndrome and assesses for contiguous deletions involving the CYBB gene linked to X-linked CGD.
TEST-4164 YARS1 Gene DI‑CMTC Genetic Test This test evaluates the entire coding sequence of the YARS1 gene for pathogenic variants associated with DI‑CMTC.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the YARS1 gene", "Single-nucleotide variants", "Insertions", "Deletions"] Parameters [] Preparation ["A documented clinical history must be completed before sample collection", "A formal genetic counselling session must be completed before sample collection", "Pedigree chart construction must be completed before sample collection"] Indications ["Suspected diagnosis of distal hereditary motor neuropathy with cataracts and mild intellectual disability (DI‑CMTC)", "Genetic aetiology suspected"] Measurement technique Confirm with laboratory Codes LOINC: 51966-5 ICD-10: G60.0 Clinical summary This test evaluates the entire coding sequence of the YARS1 gene for pathogenic variants associated with DI‑CMTC.
TEST-5259 YARS2 Gene Myopathy, Lactic Acidosis, and Sideroblastic Anemia Type 2 Genetic Test This genetic test analyzes the YARS2 gene to identify mutations causing Myopathy, Lactic Acidosis, and Sideroblastic Anemia type 2 (MLASA2).	Peripheral Whole Blood (EDTA) or Buccal Swab / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (Indels)", "Splice-site aberrations", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of MLASA2", "Family history of MLASA2", "Evaluation of unexplained myopathy, lactic acidosis, or sideroblastic anemia"] Measurement technique Confirm with laboratory Codes LOINC: 101645-1 ICD-10: D64.0, G71.3, E87.2 Clinical summary This genetic test analyzes the YARS2 gene to identify mutations causing Myopathy, Lactic Acidosis, and Sideroblastic Anemia type 2 (MLASA2).
TEST-2711 ZBTB24 Gene ICF Syndrome Type 2 Genetic Test This diagnostic test evaluates the ZBTB24 gene for pathogenic variants associated with Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 2 (ICF2).	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ZBTB24 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["Genetic counseling session required", "Informed consent required", "Fasting is not needed"] Indications ["Suspected Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 2 (ICF2)", "Recurrent infections", "Distinct facial features", "Chromosomal instability"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D82.8 Clinical summary This diagnostic test evaluates the ZBTB24 gene for pathogenic variants associated with Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 2 (ICF2).
TEST-4887 ZBTB24 Gene ICF Syndrome Type 2 Genetic Testing Test This diagnostic test evaluates the ZBTB24 gene for mutations associated with Immunodeficiency-Centromeric Instability-Facial Anomalies (ICF) Syndrome Type 2.	Peripheral Whole Blood (EDTA or FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ZBTB24 gene mutations", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Splice-site alterations"] Parameters [] Preparation ["Genetic counselling session required before sample collection", "Informed consent is mandatory"] Indications ["Suspected ICF Syndrome Type 2", "Recurrent infections", "Facial dysmorphism", "Family history suggestive of ICF", "Neonates with low immunoglobulins"] Measurement technique Confirm with laboratory Codes LOINC: 92747-3 ICD-10: D81.8 Clinical summary This diagnostic test evaluates the ZBTB24 gene for mutations associated with Immunodeficiency-Centromeric Instability-Facial Anomalies (ICF) Syndrome Type 2.
TEST-4608 ZMPSTE24 Gene Sequencing for Lethal Restrictive Dermopathy Test This test evaluates the ZMPSTE24 gene for pathogenic variants associated with lethal restrictive dermopathy.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ZMPSTE24 gene"] Parameters [] Preparation [] Indications ["Diagnosis of suspected lethal restrictive dermopathy", "Carrier screening for ZMPSTE24 mutations", "Prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: Q80.8 Clinical summary This test evaluates the ZMPSTE24 gene for pathogenic variants associated with lethal restrictive dermopathy.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.